4//SEC Filing
Nemus Bioscience, Inc. 4
Accession 0001140361-14-044454
$SKYECIK 0001516551operating
Filed
Dec 7, 7:00 PM ET
Accepted
Dec 8, 4:43 PM ET
Size
8.1 KB
Accession
0001140361-14-044454
Insider Transaction Report
Form 4
LYKOS COSMAS N
DirectorChairman of the Board10% Owner
Transactions
- Award
Stock Option (Right to Buy)
2014-12-04+125,000→ 125,000 totalExercise: $0.42Exp: 2024-11-21→ Common Stock (125,000 underlying)
Holdings
- 3,374,400
Common Stock
- 1,110,000
Warrant to Purchase Common Stock
Exercise: $1.00Exp: 2023-06-20→ Common Stock (1,110,000 underlying)
Footnotes (3)
- [F1]The warrant is immediately exercisable.
- [F2]The Board of Directors of the Company approved the grant of Stock Options on November 21, 2014, at an exercise price of fair market value. The Company engaged an independent third party to establish the fair market value on the date of grant. On December 4, 2014, the Board of Directors of the Company accepted the valution report and set the exercise price at $0.42 per share.
- [F3]Reporting Person's right to receive Stock Options vest over a five year period, with the first 20% of the total Stock Options vesting on the one year anniversary of the grant date the remainder of the shares will vest in equal installments on a annual basis thereafter, such that the Stock Options are fully vested on November 21, 2019.
Documents
Issuer
Nemus Bioscience, Inc.
CIK 0001516551
Entity typeoperating
IncorporatedNV
Related Parties
1- filerCIK 0001516551
Filing Metadata
- Form type
- 4
- Filed
- Dec 7, 7:00 PM ET
- Accepted
- Dec 8, 4:43 PM ET
- Size
- 8.1 KB